Review
doi: 10.1016/j.pain.2009.03.013.
Epub 2009 Apr 10.
Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?
Affiliations
- PMID: 19362418
- DOI: 10.1016/j.pain.2009.03.013
Item in Clipboard
Review
Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?
Pain.
2009 Jun.
No abstract available
Similar articles
-
What can we learn from failed neuropathic pain trials?Neurology. 2008 Jan 22;70(4):250-1. doi: 10.1212/01.wnl.0000298088.76718.18. Neurology. 2008. PMID: 18209199 No abstract available.
-
Toward a definition of pharmacoresistant neuropathic pain.Eur J Pain. 2009 May;13(5):439-40. doi: 10.1016/j.ejpain.2009.02.008. Epub 2009 Mar 25. Eur J Pain. 2009. PMID: 19324579 No abstract available.
-
[Drug treatment of pain originating from the peripheral nervous system].Ned Tijdschr Geneeskd. 1990 Jan 13;134(2):63-8. Ned Tijdschr Geneeskd. 1990. PMID: 1967488 Review. Dutch. No abstract available.
-
Peripheral control of inflammatory but not neuropathic pain by endogenous cholinergic system.Pharmacology. 2011;88(1-2):18-25. doi: 10.1159/000328409. Epub 2011 Jul 1. Pharmacology. 2011. PMID: 21720188
-
Neuropathic pain in leprosy.Lepr Rev. 2004 Mar;75(1):7-18. Lepr Rev. 2004. PMID: 15072122 Review.
Cited by
-
Curcumin alleviates pain and improves cognitive impairment in a rat model of cobra venom-induced trigeminal neuralgia.J Pain Res. 2018 Jun 20;11:1095-1104. doi: 10.2147/JPR.S162668. eCollection 2018. J Pain Res. 2018. PMID: 29950886 Free PMC article.
-
The antinociceptive effects of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opioid receptors.Oncotarget. 2016 Apr 12;7(15):20455-68. doi: 10.18632/oncotarget.7973. Oncotarget. 2016. PMID: 26967251 Free PMC article.
-
Role of spinal cyclooxygenase in human postoperative and chronic pain.Anesthesiology. 2010 May;112(5):1225-33. doi: 10.1097/ALN.0b013e3181d94dc0. Anesthesiology. 2010. PMID: 20395820 Free PMC article. Clinical Trial.
-
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain.Pharmaceutics. 2023 Jun 23;15(7):1799. doi: 10.3390/pharmaceutics15071799. Pharmaceutics. 2023. PMID: 37513986 Free PMC article. Review.
-
Challenges of neuropathic pain: focus on diabetic neuropathy.J Neural Transm (Vienna). 2020 Apr;127(4):589-624. doi: 10.1007/s00702-020-02145-7. Epub 2020 Feb 8. J Neural Transm (Vienna). 2020. PMID: 32036431 Free PMC article. Review.
References
-
- Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153-1169.
-
- Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5:143-149.
-
- Bingham S, Beswick PJ, Bountra C, Brown T, Campbell IB, Chessell IP, Clayton N, Collins SD, Pavey PT, Goodland H, Gray N, Haslam C, Hatcher JP, Hunter AJ, Lucas F, Murkitt G, Naylor A, Pickup E, Sargent B, Summerfield SG, Stevens A, Stratton SC, Wiseman J. The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. J Pharmacol Exp Ther. 2005;312:1161-1169.
-
- Boswell DJ, Ostergaard K, Philipson RS, Hodge RA, Blum D, Brown JC, Quessy SN. Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies. Med J Med. 2008;10:259.
-
- Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Int Med. 1987;147:1442-1444.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
